Loading organizations...
Loading organizations...
Generic pharmaceutical company developing niche topical products.
Vitruvias Therapeutics has raised $11.5M across 1 funding round.
Vitruvias Therapeutics has raised $11.5M in total across 1 funding round.
Vitruvias Therapeutics has raised $11.5M in total across 1 funding round.
Vitruvias Therapeutics's investors include Jason Wild, Michael Altman.
Vitruvias Therapeutics has raised $11.5M across 1 funding round. Most recently, it raised $11.5M Series A in January 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 5, 2018 | $11.5M Series A | Jason Wild, Michael Altman |